HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging: Diagnostic Pathways and Metabolites for Renal Tumor Entities.

AbstractBACKGROUND:
Correct tumor subtyping of primary renal tumors is essential for treatment decision in daily routine. Most of the tumors can be classified based on morphology alone. Nevertheless, some diagnoses are difficult, and further investigations are needed for correct tumor subtyping. Besides histochemical investigations, high-mass-resolution matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI) can detect new diagnostic biomarkers and hence improve the diagnostic.
PATIENTS AND METHODS:
Formalin-fixed paraffin embedded tissue specimens from clear cell renal cell carcinoma (ccRCC, n = 552), papillary renal cell carcinoma (pRCC, n = 122), chromophobe renal cell carcinoma (chRCC, n = 108), and renal oncocytoma (rO, n = 71) were analyzed by high-mass-resolution MALDI fourier-transform ion cyclotron resonance (FT-ICR) MSI. The SPACiAL pipeline was executed for automated co-registration of histological and molecular features. Pathway enrichment and pathway topology analysis were performed to determine significant differences between RCC subtypes.
RESULTS:
We discriminated the four histological subtypes (ccRCC, pRCC, chRCC, and rO) and established the subtype-specific pathways and metabolic profiles. rO showed an enrichment of pentose phosphate, taurine and hypotaurine, glycerophospholipid, amino sugar and nucleotide sugar, fructose and mannose, glycine, serine, and threonine pathways. ChRCC is defined by enriched pathways including the amino sugar and nucleotide sugar, fructose and mannose, glycerophospholipid, taurine and hypotaurine, glycine, serine, and threonine pathways. Pyrimidine, amino sugar and nucleotide sugar, glycerophospholipids, and glutathione pathways are enriched in ccRCC. Furthermore, we detected enriched phosphatidylinositol and glycerophospholipid pathways in pRCC.
CONCLUSION:
In summary, we performed a classification system with a mean accuracy in tumor discrimination of 85.13%. Furthermore, we detected tumor-specific biomarkers for the four most common primary renal tumors by MALDI-MSI. This method is a useful tool in differential diagnosis and biomarker detection.
AuthorsFranziska Erlmeier, Na Sun, Jian Shen, Annette Feuchtinger, Achim Buck, Verena M Prade, Thomas Kunzke, Peter Schraml, Holger Moch, Michael Autenrieth, Wilko Weichert, Arndt Hartmann, Axel Walch
JournalOncology (Oncology) Vol. 101 Issue 2 Pg. 126-133 ( 2023) ISSN: 1423-0232 [Electronic] Switzerland
PMID36198279 (Publication Type: Journal Article)
Copyright© 2022 S. Karger AG, Basel.
Chemical References
  • hypotaurine
  • Mannose
  • Taurine
  • Biomarkers, Tumor
  • Transcription Factors
  • Amino Sugars
Topics
  • Humans
  • Carcinoma, Renal Cell (diagnostic imaging, metabolism)
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
  • Mannose
  • Kidney Neoplasms (metabolism)
  • Taurine
  • Biomarkers, Tumor
  • Transcription Factors
  • Amino Sugars
  • Lasers

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: